Experimental evolution in morbidostat reveals converging genomic trajectories on the path to triclosan resistance

por Leyn, Semen A., Zlamal, Jaime E., Kurnasov, Oleg V., Li, Xiaoqing, Elane, Marinela, Myjak, Lourdes, Godzik, Mikolaj, de Crecy, Alban, Garcia-Alcalde, Fernando, Ebeling, Martin, Osterman, Andrei L.
Publicado 2021

A deimmunized and pharmacologically optimized Toll-like receptor 5 agonist for therapeutic applications

por Mett, Vadim, Kurnasov, Oleg V., Bespalov, Ivan A., Molodtsov, Ivan, Brackett, Craig M., Burdelya, Lyudmila G., Purmal, Andrei A., Gleiberman, Anatoli S., Toshkov, Ilia A., Burkhart, Catherine A., Kogan, Yakov N., Andrianova, Ekaterina L., Gudkov, Andrei V., Osterman, Andrei L.
Publicado 2021

Cancer Relevance of Circulating Antibodies Against LINE-1 Antigens in Humans

por Vylegzhanina, Alexandra V., Bespalov, Ivan A., Novototskaya-Vlasova, Ksenia A., Hall, Brandon M., Gleiberman, Anatoli S., Yu, Han, Leontieva, Olga V., Leonova, Katerina I., Kurnasov, Oleg V., Osterman, Andrei L., Dy, Grace K., Komissarov, Alexey A., Vasilieva, Elena, Gehlhausen, Jeff, Iwasaki, Akiko, Ambrosone, Christine B., Tsuji, Takemasa, Matsuzaki, Junko, Odunsi, Kunle, Andrianova, Ekaterina L., Gudkov, Andrei V.
Publicado 2023